alphaveSENORES₹1,468.00

Senores Pharmaceuticals Limited

₹ CrorePeersSANOFI INNOVACAP MOREPENLAB IOLCP FDC PGHL SANOFICONR ORCHPHARMAMcap ₹6,760 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	198.9	331.4	331.4
+ Capital Work-in-Progress	44.2	17.5	17.5
+ Investment Property	0.0	24.6	24.6
+ Goodwill	38.2	46.6	46.6
+ Other Intangibles	54.3	106.8	106.8
+ Intangibles under Development	128.3	232.0	232.0
+ Non-current Investments	0.0	4.3	4.3
+ Long-term Loans	0.0	4.2	4.2
+ Other Non-current Financial Assets	5.2	10.2	10.2
Non-current Financial Assets	5.2	18.7	18.7
+ Deferred Tax Assets	18.7	0.0	0.0
+ Other Non-current Assets	7.4	—	—
Total Non-current Assets	504.4	791.4	791.4
Current Assets
+ Inventories	56.6	89.3	89.3
+ Trade Receivables	123.9	324.8	324.8
+ Cash & Cash Equivalents	105.4	45.6	45.6
+ Other Bank Balances	280.1	114.1	114.1
+ Other Current Financial Assets	117.0	172.7	172.7
Current Financial Assets	626.4	657.1	657.1
+ Other Current Assets	39.5	66.0	66.0
Total Current Assets	722.4	812.4	812.4
Total Assets	1,226.9	1,603.8	1,603.8
Equity
+ Equity Share Capital	46.1	46.1	46.1
+ Other Equity / Reserves	740.1	887.6	887.6
Equity — Owners of Parent	786.2	933.6	933.6
+ Minority Interest	26.1	30.9	30.9
Total Equity	812.2	964.5	964.5
Liabilities
+ Borrowings — Non-current	162.5	194.9	194.9
+ Other Non-current Financial Liab	8.2	13.2	13.2
Non-current Financial Liabilities	170.7	208.1	208.1
+ Provisions — Non-current	3.3	6.6	6.6
+ Deferred Tax Liabilities	0.0	0.6	0.6
Non-current Liabilities	173.9	215.3	215.3
+ Borrowings — Current	142.3	132.2	132.2
+ Trade Payables	67.2	234.7	234.7
+ Other Current Financial Liab	9.6	19.4	19.4
Current Financial Liabilities	219.1	386.3	386.3
+ Provisions — Current	2.1	2.7	2.7
+ Current Tax Liabilities	13.5	20.2	20.2
+ Other Current Liabilities	6.0	14.8	14.8
Current Liabilities	240.7	424.0	424.0
Total Liabilities	414.6	639.3	639.3
Total Equity & Liabilities	1,226.9	1,603.8	1,603.8
Assets — additional as-filed lines
+ Biological Assets (other than bearer plants)	9.4	13.9	13.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	15.5	11.9	11.9
+ Dues to Other Creditors — Current	51.7	222.8	222.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.